Efficacy of risperidone in the management of suicidality in major depressive disorder.

Trial Profile

Efficacy of risperidone in the management of suicidality in major depressive disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Feb 2012

At a glance

  • Drugs Risperidone (Primary)
  • Indications Depression; Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Feb 2012 Primary outcome amended as reported by ClinicalTrials.gov.
    • 21 Feb 2012 Actual patient number changed from 24 to 30 as reported by ClinicalTrials.gov.
    • 13 Oct 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top